Literature DB >> 2803941

Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa.

S A Cartlidge1, J B Elder.   

Abstract

Acid soluble proteins from 23 samples of normal human gastrointestinal mucosa derived from four normal adult organ donors were extracted and subjected to specific radiommunoassays for transforming growth factor alpha (TGF alpha) and urogastrone epidermal growth factor (URO-EGF). All tissues were found to contain immunoreactive TGF alpha and levels ranged from 57 to 4,776 pg-1 wet weight of tissue. Although levels varied between tissue donors, the distribution of TGF alpha throughout the gastrointestinal tract appeared similar in all cases. URO-EGF levels were much lower (0-216 pg g-1 wet weight). TGF alpha levels in extracts of gastrointestinal mucosa from a 7-year-old female donor were higher and the observed distribution was markedly different from adult levels. URO-EGF was not detected in mucosal or submucosal tissue extracts from this patient. Further studies in juveniles are indicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803941      PMCID: PMC2247287          DOI: 10.1038/bjc.1989.334

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

Review 1.  Epidermal growth factor and transforming growth factor alpha.

Authors:  A W Burgess
Journal:  Br Med Bull       Date:  1989-04       Impact factor: 4.291

2.  The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.

Authors:  L P Bullock; P L Barthe; I Mowszowicz; D N Orth; C W Bardin
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

3.  The identification of urogastrone in serum, saliva, and gastric juice.

Authors:  H Gregory; S Walsh; C R Hopkins
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

4.  Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.

Authors:  Y Hirata; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

5.  Cellular localisation of human urogastrone/epidermal growth factor.

Authors:  J B Elder; G Williams; E Lacey; H Gregory
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

6.  Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.

Authors:  M A Anzano; A B Roberts; C A Meyers; A Komoriya; L C Lamb; J M Smith; M B Sporn
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Effect of thyroxine, testosterone, and corticosterone on nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mouse submaxillary gland: dissociation of NGF and EGF responses.

Authors:  P Walker; M E Weichsel; S B Hoath; R E Poland; D A Fisher
Journal:  Endocrinology       Date:  1981-08       Impact factor: 4.736

8.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.

Authors:  A B Roberts; L C Lamb; D L Newton; M B Sporn; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Hormonal regulation of epidermal growth factor and protease in the submandibular gland of the adult mouse.

Authors:  E W Gresik; I Schenkein; H van der Noen; T Barka
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

View more
  28 in total

Review 1.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?

Authors:  W M Wong; R J Playford; N A Wright
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Expression of transforming growth factor alpha in human tissues: immunohistochemical study and northern blot analysis.

Authors:  W Yasui; Z Q Ji; H Kuniyasu; A Ayhan; H Yokozaki; H Ito; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 3.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

4.  Cytokines and Helicobacter pylori--a growth area.

Authors:  R Playford
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

5.  Epidermal growth factor in saliva and gastric juice: response to histamine.

Authors:  A M Tunio; M Hobsley
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

6.  Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.

Authors:  C S Potten; G Owen; D Hewitt; C A Chadwick; H Hendry; B I Lord; L B Woolford
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells.

Authors:  S Chakrabarty; S Rajagopal; S Huang
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

8.  Growth factor regulation of proliferation in primary cultures of small intestinal epithelium.

Authors:  C Booth; G S Evans; C S Potten
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

9.  Immunoreactivities for epidermal growth factor (EGF) and for EGF receptors in rats with gastric ulcers.

Authors:  H Lee; H A Hansson; E Norström; H F Helander
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

10.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.